期刊文献+

1例重症溃疡性结肠炎患者的营养支持方案分析 被引量:4

Analysis of nutrition support for a severe case of ulcerative colitis
下载PDF
导出
摘要 1例30岁男性患者,因"腹泻半月、解黏液脓血便一周"入院,诊断为溃疡性结肠炎(急性,初发型,重度,全结肠,活动期)。入院第7天患者解鲜血便5次,量约800 m L,伴有乏力、心慌、冷汗,BP 86/50 mm Hg,P 100次·min-1,予禁食、暂停肠内营养及对症处理。临床药师协助医生拟定肠外营养支持方案,患者使用肠外营养第2天、颈内静脉置管术后3 h输注其他静脉液体后突发剧烈右侧胸痛,不能排除导管栓塞或疾病本身导致的肺栓塞、心肌梗死,立即对肠外营养做出调整:暂停使用脂肪乳。经过13 d的肠外营养支持,患者病情明显好转并恢复经口摄入。 A 30-year-old male patient was admitted to the hospital with the pathogeny of two weeks' diarrhea and one week's purulent blood and mucoid stool, and diagnosed with ulcerative colitis (acute, early onset, severe, colon activity). The 7th day after hospitalization, the patient excreted blood stool for 5 times with a total volumn of 800 mL, accompanied with fatigue, palpitation, cold sweat, blood pressure 86/50 mm Hg, a pulse of 100 beats per minute. The patient was treated with the therapy of fasting and suspended enteral nutrition (EN). Clinical pharmacists assisted with physicians to make the scheme of parenteral nutrition (PN) support. Two days after the sustained usage of PN, and 3 hours after jugular vein catheterization, the patient developed a sudden severe pain of right chest when he received the infusion of venous fluids. We could not exclude the possibility of transcatheter embolization, pulmonary embolism associated with the disease or myocardial infarction, so clinical pharmacists suspended the usage of fat emulsion. After 13 days of PN support, condition of the patient signiifcantly improved, then the patient was transferred to oral intake.
出处 《中国药物应用与监测》 CAS 2015年第3期157-159,共3页 Chinese Journal of Drug Application and Monitoring
关键词 临床药师 溃疡性结肠炎 营养支持 血栓 脂肪乳 Clinical pharmacist Ulcerative colitis Nutrition support Thrombus Fat emulsion
  • 相关文献

参考文献9

二级参考文献41

  • 1朱峰,王礼建,钱家鸣,姚方,伍东升,徐彤.肠内营养在克罗恩病治疗中的应用[J].中国临床营养杂志,2005,13(6):356-360. 被引量:14
  • 2欧阳钦,胡品津,钱家鸣,郑家驹,胡仁伟.对我国炎症性肠病诊断治疗规范的共识意见[J].胃肠病学,2007,12(8):488-495. 被引量:751
  • 3Rutgeerts P.Medical therapy of inflammatory bowel disease[J].Digestion,1998,59 (5):453-469.
  • 4Vucelic B.Inflammatory bowel diseases:controversies in the use of diagnostic procedures[J].Dig Dis,2009,27 (3):269-277.
  • 5Srirajaskanthan R,Winter M,Muller AF.Venous thrombosis in inflammatory bowel disease[J].Eur J Gastroenterol Hepatol,2005,17 (7):697-700.
  • 6Polińska B,Matowicka-Karna J,Kemona H.Assessment of the influence of the inflammatory process on the activation of blood platelets and morphological parameters in patients with ulcerative colitis (colitis ulcerosa)[J].Folia Histochem Cytobiol,2011,49 (1):119-124.
  • 7Larsen TB,Nielsen JN,Fredholm L,et al.Platelets and anticoagulant capacity in patients with inflammatory bowel disease[J].Pathophysiol Haemost Thromb,2002,32 (2):92-96.
  • 8Kapsoritakis AN,Koukourakis MI,Sfiridaki A,et al.Mean platelet volume:a useful marker of inflammatory bowel disease activity[J].Am J Gastroenterol,2001,96 (3):776-781.
  • 9Kume K,Yamasaki M,Tashiro M,et al.Activations of coagulation and fibrinolysis secondary to bowel inflammation in patients with ulcerative colitis[J].Intern Med,2007,46 (17):1323-1329.
  • 10Turgut U,Huseyin S,Nergis D,et al.Looking for our ten years results for coronary heart disease and ischemic stroke group for the standpoint of haemostasis[J].Turk J Haematol,2002,19 (2):255-263.

共引文献120

同被引文献52

引证文献4

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部